The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CO | -52% | -84.21% | -30.87% | -87% |
| S&P | +15.06% | +95.03% | +14.29% | +629% |
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.
The company received an acquisition offer.
CO earnings call for the period ending March 31, 2018.
Currently no data to display
Currently no data to display.
Currently no data to display.
| Metric | YoY Change |
|---|
CO earnings call for the period ending September 30, 2021.
CO earnings call for the period ending June 30, 2021.
CO earnings call for the period ending March 31, 2021.
CO earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
